CHARBEL
The computed 12-month bankruptcy probability of CHARBEL is 0.2% (very low). The 2024 annual accounts show negative equity (€-138k) and a net result of €14k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 6553 sector peers (fiscal year 2024). The company has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-138k |
| Net result | €14k |
| Better than sector | 5% |
| Active | 25 yrs |
Fragile profile, watch profitability in particular.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -140.1% | 66.7% | |
| Net result | €14k | €46k | |
| Equity | €-138k | €79k | |
| Gross operating margin | €33k | €78k | |
| Staff costs | €1k | €21k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €26k |
| Net profit | €14k |
| Cash flow | €26k |
| Staff costs | €1k |
| Income taxes | - |
| Dividends | - |
| Total assets | €99k |
| Equity | €-138k |
| Debt | €237k |
| of which ≤ 1y | €237k |
| of which > 1y | - |
| Working capital | €-222k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.06 |
| Quick ratio | 0.06 |
| Working capital ratio | -224.5% |
| Solvency | -140.1% |
| Debt / equity | -1.71 |
| Long-term debt ratio | - |
| Interest coverage | 472.81 |
| Gross margin | - |
| Net margin | - |
| ROA | 13.8% |
| ROE | -9.9% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €99k |
| Fixed assets | 21/28 | €83k |
| Tangible fixed assets | 22/27 | €83k |
| Current assets | 29/58 | €15k |
| Cash & bank | 54/58 | €15k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €99k |
| Equity | 10/15 | €-138k |
| Contributions / capital | 10/11 | €19k |
| Reserves | 13 | €12k |
| Accumulated profits (losses) | 14 | €-169k |
| Amounts payable | 17/49 | €237k |
| Amounts payable within one year | 42/48 | €237k |
| Income statement | ||
| Gross operating margin | 9900 | €33k |
| Operating result | 9901 | €14k |
| Financial charges | 65 | €56 |
| Result before taxes | 9903 | €14k |
| Net result for the period | 9904 | €14k |
| Result to be appropriated | 9905 | €14k |
| NACE primary | Human health(86230) |
| Legal form | Private limited company(610) |
| Incorporation | 27-02-2001 |
| Status | Active |
| Postal code | 1040 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21363B0438/00K004 | Brussels | 163 m² | 1 · 163 m² | 18.5 m · 5 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
28-12-2023 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0474.195.980",
"name_full": "CHARBEL"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"old": "Soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e",
"changed": false
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | CHARBEL |